4.5 Review

A Review on the Role of Endogenous Neurotrophins and Schwann Cells in Axonal Regeneration

期刊

JOURNAL OF NEUROIMMUNE PHARMACOLOGY
卷 17, 期 3-4, 页码 398-408

出版社

SPRINGER
DOI: 10.1007/s11481-021-10034-3

关键词

Neurotrophic factors; Schwann cells; Regeneration; Brain-derived neurotrophic factor; Pituitary adenylyl cyclase-activating peptide; Plasticity

资金

  1. Manipal Academy of Higher Education, Manipal

向作者/读者索取更多资源

Peripheral nerve injuries can be caused by various factors, not just physical trauma. These injuries can lead to a wide range of manifestations and functional impairments, but currently there is no complete recovery option available. Modulating the expression of neurotrophins such as BDNF and PACAP may offer a promising treatment option for nerve injury.
Injury to the peripheral nerve is traditionally referred to acquired nerve injury as they are the result of physical trauma due to laceration, stretch, crush and compression of nerves. However, peripheral nerve injury may not be completely limited to acquired physical trauma. Peripheral nerve injury equally implies clinical conditions like Guillain-Barre syndrome (GBS), Carpal tunnel syndrome, rheumatoid arthritis and diabetes. Physical trauma is commonly mono-neuropathic as it engages a single nerve and produces focal damage, while in the context of pathological conditions the damage is divergent involving a group of the nerve causing polyneuropathy. Damage to the peripheral nerve can cause a diverse range of manifestations from sensory impairment to loss of function with unpredictable recovery patterns. Presently no treatment option provides complete or functional recovery in nerve injury, as nerve cells are highly differentiated and inert to regeneration. However, the regenerative phenotypes in Schwann cells get expressed when a signalling cascade is triggered by neurotrophins. Neurotrophins are one of the promising biomolecules that are released naturally post-injury with the potential to exhibit better functional recovery. Pharmacological intervention modulating the expression of these neurotrophins such as brain-derived neurotrophic factor (BDNF) and pituitary adenylyl cyclase-activating peptide (PACAP) can prove to be a significant treatment option as endogenous compounds which may have remarkable innate advantage showing maximum 'biological relevance'.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据